{{Rsnum
|rsid=11132186
|Chromosome=4
|position=183517570
|Orientation=plus
|GMAF=0.2916
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 46.2 | 47.7 | 6.2
| HCB | 0.0 | 0.0 | 0.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 61.9 | 31.7 | 6.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs11132186]] is a SNP on ch 4 near the inhibitor of growth family, member 2 [[ING2]] gene.

A pathway-based case-control approach assessing the association of 207 SNPs in 26 DNA repair genes in 800 patients with [[bladder cancer]] concluded that the odds ratio of the homozygous variant [[rs11132186]](T;T) genotype was 0.52 (CI: 0.32-0.83, p = .005).
{{PMID Auto
|PMID=21692063
|Title=Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer
|OA=1
}}

{{on chip | HumanOmni1Quad}}